Analogic Corporation Signs Agreement With Sphere Medical To Develop Innovative Glucose Monitor For Critical Care Market

PEABODY, Mass.--(BUSINESS WIRE)--July 24, 2006--Analogic Corporation (NASDAQ: ALOG - News) today announced that the Company has entered into an agreement with Sphere Medical of Cambridge, UK, to develop and manufacture instruments for the monitoring of key blood parameters, such as glucose, blood gases, and electrolytes, in critical care patients.

MORE ON THIS TOPIC